BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 12692076)

  • 1. Molecular cloning, chromosomal localization of human peripheral-type benzodiazepine receptor and PKA regulatory subunit type 1A (PRKAR1A)-associated protein PAP7, and studies in PRKAR1A mutant cells and tissues.
    Liu J; Matyakhina L; Han Z; Sandrini F; Bei T; Stratakis CA; Papadopoulos V
    FASEB J; 2003 Jun; 17(9):1189-91. PubMed ID: 12692076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification, localization, and function in steroidogenesis of PAP7: a peripheral-type benzodiazepine receptor- and PKA (RIalpha)-associated protein.
    Li H; Degenhardt B; Tobin D; Yao ZX; Tasken K; Papadopoulos V
    Mol Endocrinol; 2001 Dec; 15(12):2211-28. PubMed ID: 11731621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depletion of type IA regulatory subunit (RIalpha) of protein kinase A (PKA) in mammalian cells and tissues activates mTOR and causes autophagic deficiency.
    Mavrakis M; Lippincott-Schwartz J; Stratakis CA; Bossis I
    Hum Mol Genet; 2006 Oct; 15(19):2962-71. PubMed ID: 16963469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A transgenic mouse bearing an antisense construct of regulatory subunit type 1A of protein kinase A develops endocrine and other tumours: comparison with Carney complex and other PRKAR1A induced lesions.
    Griffin KJ; Kirschner LS; Matyakhina L; Stergiopoulos SG; Robinson-White A; Lenherr SM; Weinberg FD; Claflin ES; Batista D; Bourdeau I; Voutetakis A; Sandrini F; Meoli EM; Bauer AJ; Cho-Chung YS; Bornstein SR; Carney JA; Stratakis CA
    J Med Genet; 2004 Dec; 41(12):923-31. PubMed ID: 15591278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PAP7, a PBR/PKA-RIalpha-associated protein: a new element in the relay of the hormonal induction of steroidogenesis.
    Liu J; Li H; Papadopoulos V
    J Steroid Biochem Mol Biol; 2003 Jun; 85(2-5):275-83. PubMed ID: 12943713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular cloning, genomic organization, chromosomal mapping and subcellular localization of mouse PAP7: a PBR and PKA-RIalpha associated protein.
    Liu J; Cavalli LR; Haddad BR; Papadopoulos V
    Gene; 2003 Apr; 308():1-10. PubMed ID: 12711385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of the Carney complex gene 1 (protein kinase A regulatory subunit 1A) inhibits SMAD3 expression and TGF beta-stimulated apoptosis in adrenocortical cells.
    Ragazzon B; Cazabat L; Rizk-Rabin M; Assie G; Groussin L; Fierrard H; Perlemoine K; Martinez A; Bertherat J
    Cancer Res; 2009 Sep; 69(18):7278-84. PubMed ID: 19738044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular and functional analysis of PRKAR1A and its locus (17q22-24) in sporadic adrenocortical tumors: 17q losses, somatic mutations, and protein kinase A expression and activity.
    Bertherat J; Groussin L; Sandrini F; Matyakhina L; Bei T; Stergiopoulos S; Papageorgiou T; Bourdeau I; Kirschner LS; Vincent-Dejean C; Perlemoine K; Gicquel C; Bertagna X; Stratakis CA
    Cancer Res; 2003 Sep; 63(17):5308-19. PubMed ID: 14500362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenal pathophysiology: lessons from the Carney complex.
    Groussin L; Cazabat L; René-Corail F; Jullian E; Bertherat J
    Horm Res; 2005; 64(3):132-9. PubMed ID: 16192737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of mouse models to understand the molecular basis of tissue-specific tumorigenesis in the Carney complex.
    Kirschner LS
    J Intern Med; 2009 Jul; 266(1):60-8. PubMed ID: 19522826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PRKAR1A Mutations and protein kinase A interactions with other signaling pathways in the adrenal cortex.
    Robinson-White A; Meoli E; Stergiopoulos S; Horvath A; Boikos S; Bossis I; Stratakis CA
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2380-8. PubMed ID: 16569736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein kinase A subunit expression is altered in Bloom syndrome fibroblasts and the BLM protein is increased in adrenocortical hyperplasias: inverse findings for BLM and PRKAR1A.
    Heyerdahl SL; Boikos S; Horvath A; Giatzakis C; Bossis I; Stratakis CA
    Horm Metab Res; 2008 Jun; 40(6):391-7. PubMed ID: 18401830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular analysis of the cyclic AMP-dependent protein kinase A (PKA) regulatory subunit 1A (PRKAR1A) gene in patients with Carney complex and primary pigmented nodular adrenocortical disease (PPNAD) reveals novel mutations and clues for pathophysiology: augmented PKA signaling is associated with adrenal tumorigenesis in PPNAD.
    Groussin L; Kirschner LS; Vincent-Dejean C; Perlemoine K; Jullian E; Delemer B; Zacharieva S; Pignatelli D; Carney JA; Luton JP; Bertagna X; Stratakis CA; Bertherat J
    Am J Hum Genet; 2002 Dec; 71(6):1433-42. PubMed ID: 12424709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 17q22-24 chromosomal losses and alterations of protein kinase a subunit expression and activity in adrenocorticotropin-independent macronodular adrenal hyperplasia.
    Bourdeau I; Matyakhina L; Stergiopoulos SG; Sandrini F; Boikos S; Stratakis CA
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3626-32. PubMed ID: 16772351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory subunit type I-alpha of protein kinase A (PRKAR1A): a tumor-suppressor gene for sporadic thyroid cancer.
    Sandrini F; Matyakhina L; Sarlis NJ; Kirschner LS; Farmakidis C; Gimm O; Stratakis CA
    Genes Chromosomes Cancer; 2002 Oct; 35(2):182-92. PubMed ID: 12203783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PRKAR1A mutations in primary pigmented nodular adrenocortical disease.
    Cazabat L; Ragazzon B; Groussin L; Bertherat J
    Pituitary; 2006; 9(3):211-9. PubMed ID: 17036196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations of the PRKAR1A gene in Cushing's syndrome due to sporadic primary pigmented nodular adrenocortical disease.
    Groussin L; Jullian E; Perlemoine K; Louvel A; Leheup B; Luton JP; Bertagna X; Bertherat J
    J Clin Endocrinol Metab; 2002 Sep; 87(9):4324-9. PubMed ID: 12213893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein kinase A alterations in endocrine tumors.
    Yu B; Ragazzon B; Rizk-Rabin M; Bertherat J
    Horm Metab Res; 2012 Sep; 44(10):741-8. PubMed ID: 22752956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A PRKAR1A mutation associated with primary pigmented nodular adrenocortical disease in 12 kindreds.
    Groussin L; Horvath A; Jullian E; Boikos S; Rene-Corail F; Lefebvre H; Cephise-Velayoudom FL; Vantyghem MC; Chanson P; Conte-Devolx B; Lucas M; Gentil A; Malchoff CD; Tissier F; Carney JA; Bertagna X; Stratakis CA; Bertherat J
    J Clin Endocrinol Metab; 2006 May; 91(5):1943-9. PubMed ID: 16464939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence that PKA activity is constitutively activated in human GH-secreting adenoma cells in a patient with Carney complex harbouring a PRKAR1A mutation.
    Takano K; Yasufuku-Takano J; Morita K; Mori S; Takei M; Osamura RY; Teramoto A; Fujita T
    Clin Endocrinol (Oxf); 2009 May; 70(5):769-75. PubMed ID: 19178533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.